These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30723513)

  • 1. Clinical Effects and Safety of Tongxieyaofang on Diarrhea Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized Trails.
    Zhou Y; Han S; He Y
    Evid Based Complement Alternat Med; 2019; 2019():4893876. PubMed ID: 30723513
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy and mechanism of acupuncture combined with
    Wang SS; Wang XR; Yang RY; Xu Y; Li MY
    Zhongguo Zhen Jiu; 2020 Jun; 40(6):605-9. PubMed ID: 32538010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: Evidence for clinical practice and future trials.
    Liang SB; Cao HJ; Kong LY; Wei JL; Robinson N; Yang SH; Zhu SJ; Li YQ; Fei YT; Han M; Liu JP
    Front Pharmacol; 2022; 13():904657. PubMed ID: 36091782
    [No Abstract]   [Full Text] [Related]  

  • 4. Acupuncture combined with Tongxieyaofang for diarrhea-type irritable bowel syndrome: A protocol for meta-analysis.
    Li YL; Yao CJ; Lei R; Xie F; Xiong Q; Luo LH; Feng PM
    Medicine (Baltimore); 2020 Nov; 99(48):e23457. PubMed ID: 33235133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management: A meta-analysis of randomized, positive medicine-controlled trials.
    Dai YK; Li DY; Zhang YZ; Huang MX; Zhou YL; Ye JT; Wang Q; Hu L
    PLoS One; 2018; 13(2):e0192319. PubMed ID: 29408906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
    Liang SB; Han M; Cheng HJ; Zhang QY; Zhang NW; Jia BY; Robinson N; Liu JP
    Trials; 2022 Mar; 23(1):226. PubMed ID: 35313933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
    Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
    Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acupuncture for treatment of irritable bowel syndrome.
    Manheimer E; Cheng K; Wieland LS; Min LS; Shen X; Berman BM; Lao L
    Cochrane Database Syst Rev; 2012 May; 5(5):CD005111. PubMed ID: 22592702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the Chinese herbal formula TongXieYaoFang for irritable bowel syndrome: a systematic review.
    Bian Z; Wu T; Liu L; Miao J; Wong H; Song L; Sung JJ
    J Altern Complement Med; 2006 May; 12(4):401-7. PubMed ID: 16722791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External therapy of traditional Chinese medicine for treating irritable bowel syndrome with diarrhea: A systematic review and meta-analysis.
    Wei X; Wen Y; Wei Y; Liang X; Ma X; Zhang B; Tang X
    Front Med (Lausanne); 2022; 9():940328. PubMed ID: 36017012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic effect of herb-separated moxibustion at Jinsuo (GV 8)-eight-diagram points on diarrhea-type irritable bowel syndrome of liver stagnation and spleen deficiency].
    Hao LJ; Shi ZM
    Zhongguo Zhen Jiu; 2020 Jul; 40(7):702-6. PubMed ID: 32648391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tong-Xie-Yao-Fang alleviates diarrhea-predominant irritable bowel syndrome in rats via the GCN2/PERK-eIF2α-ATF4 signaling pathway.
    Zhang M; Zheng Y; Li X; Wu H; Liu P; Zhang K; Shi Z; Lv M; Wang F; Tang X
    Phytomedicine; 2022 Dec; 107():154350. PubMed ID: 36194974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials.
    Liu N; Li J; Wang Y; Zhang S
    J Ethnopharmacol; 2023 Dec; 317():116672. PubMed ID: 37328079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs.
    Wang Y; Chen N; Niu F; Li Y; Guo K; Shang X; E F; Yang C; Yang K; Li X
    Int J Colorectal Dis; 2022 Nov; 37(11):2263-2276. PubMed ID: 36251040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of systematic evaluation of efficacy of Tongxie Yaofang in treating diarrhea-predominant irritable bowel syndrome.
    Chen X; Yu X; Shi Y; Shen H
    Ann Palliat Med; 2021 Aug; 10(8):9223-9232. PubMed ID: 34488410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acupuncture for Adults with Diarrhea-Predominant Irritable Bowel Syndrome or Functional Diarrhea: A Systematic Review and Meta-Analysis.
    Guo J; Xing X; Wu J; Zhang H; Yun Y; Qin Z; He Q
    Neural Plast; 2020; 2020():8892184. PubMed ID: 33299403
    [No Abstract]   [Full Text] [Related]  

  • 18. How Tongxie-Yaofang Regulates Intestinal Synaptic Plasticity by Activating Enteric Glial Cells and NGF/TrkA Pathway in Diarrhea-Predominant Irritable Bowel Syndrome Rats.
    Lu X; Zhang S
    Drug Des Devel Ther; 2023; 17():2969-2983. PubMed ID: 37789966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acupuncture for diarrhea-predominant irritable bowel syndrome:a meta-analysis].
    Deng D; Guo K; Tan J; Huang G; Li S; Jiang Q; Xie J; Xie H; Zhang Z; Chen Y; Peng L
    Zhongguo Zhen Jiu; 2017 Aug; 37(8):907-912. PubMed ID: 29231356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of pinaverium bromide combined with flupentixol-melitracen for diarrhea-type irritable bowel syndrome: A systematic review and meta-analysis.
    Qin L; Qin J; Yang Q; Lv X; Huang L
    Medicine (Baltimore); 2019 Jan; 98(2):e14064. PubMed ID: 30633208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.